The Lazarus Pharmaceuticals

Dormant late stage compounds that will require a minimal amount of additional clinical work for approval Previously approved compounds where we can improve the profile or pursue additional indications Early stage compounds (pre-IND or phase I) that are a strategic fit Our Mission